Cargando…

ERT impact on left ventricular mass in Fabry disease

Detalles Bibliográficos
Autor principal:	Ortiz, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582195/ https://www.ncbi.nlm.nih.gov/pubmed/31245278 http://dx.doi.org/10.1016/j.ymgmr.2019.100485

Ejemplares similares

Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis
por: Lee, Chung-Lin, et al.
Publicado: (2022)

Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases
por: Ivanova, Margarita M., et al.
Publicado: (2019)

Left ventricular mass correlates with lean body mass in patients with disease-associated wasting
por: Molfino, Alessio, et al.
Publicado: (2014)

Establishing a Telemedicine Respiratory Therapy Service (eRT) in the COVID-19 Pandemic
por: Pierce, M., et al.
Publicado: (2021)

Motor involvement in Fabry disease
por: Cocozza, Sirio, et al.
Publicado: (2017)

Is the Diagnostic Value of Electrocardiography for the Measurement of Left Ventricular Mass Index Underestimated?
por: Khani, Afshin
Publicado: (2014)

Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
por: Lenders, Malte, et al.
Publicado: (2018)

Relationship between MRI derived right ventricular mass and left ventricular involvement in patients with anderson-fabry disease
por: Li, Qin, et al.
Publicado: (2015)

Comment: Why are females with Fabry disease affected?
por: Beck, Michael, et al.
Publicado: (2019)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

Is the Diagnostic Value of Electrocardiography for the Measurement of Left Ventricular Mass Index Underestimated? Reply
por: Noori, Noor Mohammad, et al.
Publicado: (2014)

Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
por: Cammisa, Marco, et al.
Publicado: (2013)

Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy
por: Kim, Woo-Shik, et al.
Publicado: (2019)

Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy
por: Sadasivan, Chandu, et al.
Publicado: (2020)

Erratum: Relationship between MRI derived right ventricular mass and left ventricular involvement in patients with anderson-fabry disease
por: Ng, Ming-Yen, et al.
Publicado: (2015)

Left ventricular pseudoaneurysm
por: Ho, Hee Hwa, et al.
Publicado: (2017)

Loss of Left Ventricular Vortex Ring in Left Ventricular Assist Device-Induced Right Ventricular Failure
por: Akiyama, Koichi, et al.
Publicado: (2023)

Concurrent depletion of skeletal muscle, fat, and left ventricular mass in patients with cirrhosis of the liver
por: Kazemi‐Bajestani, Seyyed Mohammad Reza, et al.
Publicado: (2015)

Does left ventricular function predict cardiac outcome in Anderson–Fabry disease?
por: Spinelli, Letizia, et al.
Publicado: (2020)

Fabry disease previously diagnosed as Henoch-Schonlein purpura
por: Kim, Ji Hyeong, et al.
Publicado: (2015)

Are Female Patients More Overlooked in the Diagnosis of Fabry Disease?
por: Gürdoğan, Muhammet, et al.
Publicado: (2020)

Left ventricular pseudoaneurysm and syncope
por: Martínez-Quintana, Efrén, et al.
Publicado: (2016)

Left ventricular noncompaction cardiomyopathy
por: Hawatmeh, Amer, et al.
Publicado: (2017)

Hyperhomocysteinemia and Left Ventricular Thrombus
por: Raut, Monish S, et al.
Publicado: (2017)

Fabry Disease Associated With Antiglomerular Basement Membrane Disease: Chance or Consequence
por: Terinte-Balcan, George, et al.
Publicado: (2022)

Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2019)

Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
por: Yousef, Zaheer, et al.
Publicado: (2013)

Pain in Fabry Disease: Could Spinal Cord Stimulation be a Solution?
por: Buonanno, Pasquale, et al.
Publicado: (2023)

Rare Subvalvular Left Ventricular Aneurysm
por: Raut, Monish S., et al.
Publicado: (2016)

Percutaneous left ventricular pseudoaneurysm closure
por: Hnat, Tomas, et al.
Publicado: (2020)

Arrhythmogenic Right Ventricle in Left Ventricular Non-compaction - In response to "Right Ventricular Ablation as a Therapeutic Option for Left Ventricular Hypertrabeculation / noncompaction"
por: Honarbakhsh, Shohreh, et al.
Publicado: (2014)

Left ventricular clefts – incidental finding or pathologic sign of Wilson’s disease?
por: Zhang, Kun, et al.
Publicado: (2019)

Left-ventricular diastolic dysfunction in coronavirus disease: opening Pandora’s box!
por: Magoon, Rohan
Publicado: (2021)

Mitral annular calcification: left atrial size and left ventricular dysfunction
por: Floria, Mariana, et al.
Publicado: (2016)

Screening for Fabry Disease in Left Ventricular Hypertrophy: Documentation of a Novel Mutation
por: Baptista, Ana, et al.
Publicado: (2015)

Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker
por: López-Sainz, Ángela, et al.
Publicado: (2019)

Screening for Fabry disease in unknown origin axonal polyneuropathy: to do or not to do, this is the question!
por: Rota, Eugenia, et al.
Publicado: (2020)

Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
por: Chimenti, Cristina, et al.
Publicado: (2021)

Right Ventricular Ablation as a Therapeutic Option for Left Ventricular Hypertrabeculation / Noncompaction
por: Finsterer, Josef, et al.
Publicado: (2014)

Enzyme replacement therapy (ERT) in pompe disease
por: Fiumara, Agata
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_icv5adkj44j5ucrp15c9an6n20